Vandetanib
Showing 1 - 25 of 118
Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory
Recruiting
- Advanced Malignant Neoplasm
- +3 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Cancer, Non Small Cell Lung Cancer Trial in United Kingdom (Vandetanib, Selumetinib)
Completed
- Cancer
- Non Small Cell Lung Cancer
- Vandetanib, Selumetinib
-
Headington, Oxford, United Kingdom
- +3 more
Sep 9, 2021
Invasive Breast Cancer Trial in Iowa City (Vandetanib, Placebo)
Terminated
- Invasive Breast Cancer
- Vandetanib
- Placebo
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Oct 1, 2021
Metastatic Sporadic Medullary Thyroid Cancer Patients and
Completed
- Metastatic Sporadic Medullary Thyroid Cancer
-
Milano, ItalyFondazione IRCCS Istituto Nazionale dei Tumori, Milano
Sep 29, 2021
Carcinoma, Hepatocellular, Metastatic Colorectal Cancer Trial in Bloomsbury (BTG-002814)
Completed
- Carcinoma, Hepatocellular
- Metastatic Colorectal Cancer
-
Bloomsbury, London, United KingdomUniversity College London Hospital
Jul 15, 2021
Thyroid Cancer Trial in Worldwide (300mg vandetanib, 150mg vandetanib)
Active, not recruiting
- Thyroid Cancer
- 300mg vandetanib
- 150mg vandetanib
-
Houston, Texas
- +25 more
Oct 20, 2021
Thyroid Tumors Trial in Worldwide (Vandetanib, Placebo)
Active, not recruiting
- Thyroid Neoplasms
- Vandetanib
- Placebo
-
Brussels, Belgium
- +21 more
Oct 20, 2021
Renal Cell Carcinoma, Hereditary Leiomyomatosis, Renal Cell Cancer Trial run by the NCI (Vandetanib, Metformin,
Terminated
- Renal Cell Carcinoma
- +2 more
- Vandetanib
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 12, 2021
Non Small Cell Lung Cancer Trial in Seoul (Vandetanib)
Completed
- Non Small Cell Lung Cancer
- Vandetanib
-
Seoul, Korea, Republic of
- +1 more
Dec 4, 2020
Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Type 2A, Multiple Endocrine Neoplasia Type 2B Trial run by the NCI
Completed
- Medullary Thyroid Carcinoma
- +2 more
- Vandetanib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 1, 2020
Differentiated Thyroid Cancer Trial in Worldwide (Vandetanib (SAR390530), Placebo)
Active, not recruiting
- Differentiated Thyroid Cancer
- Vandetanib (SAR390530)
- Placebo
-
Little Rock, Arkansas
- +60 more
Oct 20, 2021
Locally Advanced or Metastatic Medullary Thyroid Cancer, Medullary Thyroid Cancer Trial in Worldwide (Patient outreach,
Active, not recruiting
- Locally Advanced or Metastatic Medullary Thyroid Cancer
- Medullary Thyroid Cancer
- Patient outreach
- Vandetanib
-
St Leonards, Australia
- +33 more
Oct 20, 2021
Lip and Oral Cavity Squamous Cell Carcinoma, Oral Cavity Verrucous Carcinoma, Precancerous Condition Trial in Chicago (drug,
Completed
- Lip and Oral Cavity Squamous Cell Carcinoma
- +2 more
- vandetanib
- +5 more
-
Chicago, IllinoisUniversity of Chicago
Jan 8, 2021
Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)
Terminated
- Thyroid Cancer
- +5 more
- Lenvatinib
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jul 12, 2021
Cancer of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Cancer of the Stomach Trial in Philadelphia
Completed
- Cancer of the Esophagus
- +2 more
- Vandetanib
- +4 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 4, 2021
Vandetanib in RET -/+ Metastatic Medullary Thyroid Cancer
Completed
- Symptomatic, Aggressive, Sporadic, Unresectable, Locally
- Advanced/Metastatic Medullary Thyroid Cancer (MTC)
- Vandetanib 300 mg
-
Belgium, Belgium
- +7 more
Oct 15, 2020
GIST Trial run by the NCI (Vandetanib)
Completed
- GIST
- Vandetanib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 25, 2020
Cancer, High-grade Glioma Trial in Amsterdam (Sunitinib, vandetanib, Erlotinib)
Unknown status
- Cancer
- High-grade Glioma
- Sunitinib
- +2 more
-
Amsterdam, Noord-Holland, NetherlandsVU University Medical Center
Oct 6, 2020
NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Non-small Cell Lung Cancer Metastatic
- AZD2014
- +10 more
-
Avignon, France
- +36 more
Jul 29, 2022
Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Metastatic Breast Cancer
- AZD2014
- +18 more
-
Angers, France
- +24 more
Mar 8, 2022
Non Small Cell Lung Cancer, Lung Cancer Trial in Worldwide (Vandetanib, Pemetrexed)
Active, not recruiting
- Non Small Cell Lung Cancer
- Lung Cancer
- Vandetanib
- Pemetrexed
-
Casa Grande, Arizona
- +109 more
Oct 20, 2021
Relapsed Pediatric Solid Tumor, Refractory Pediatric Solid Tumor, Relapsed Pediatric AML Trial in Seoul (CancerSCAN™,
Recruiting
- Relapsed Pediatric Solid Tumor
- +3 more
- CancerSCAN™
- +17 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 18, 2020
Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)
Recruiting
- Medullary Thyroid Cancer
- Selpercatinib
- +2 more
-
Birmingham, Alabama
- +148 more
Jan 18, 2023
A Detailed Look At What Patients Experience In Medullary Thyroid
Not yet recruiting
- Medullary Thyroid Cancer
-
San Francisco, CaliforniaPower Life Sciences
Oct 6, 2023